Mediview Announces New Board Member (Karley)

MediView is pleased to announce the addition of Karley Yoder as a new member to MediView’s Board of Directors.

“MediView welcomes Karley to our team and Board of Directors. As part of our collaboration with GEHC, Karley brings a wealth of strategic thinking, relevant experience, and cultural alignment with MediView, the Board, and the patients and clinicians we serve. With Karley’s commercial, operational, and digital health track-record she is a great partner in MediView’s phase of growth as we lead and drive adoption of clinical data, digital, and communication solutions,” said Mina Fahim, President and CEO of MediView.

Karley Yoder is the General Manager & Chief Digital Officer for GE Healthcare’s ~$3 billion global ultrasound busines.  In this role she is responsible for digital product innovation, commercial growth, customer collaboration, AI development and third-party partnerships to accelerate the impact of digital solutions that drive clinical efficiency and enable better patient outcomes. Previously, Karley served as Vice President and General Manager for AI at GE Healthcare, where her team developed “Edison AI,” a healthcare-specific AI platform, which brought to market innovative products such as X-ray Critical Care Suite, Ultrasound SonoCNS in VolusonE10, and MR DL Recon.  Additionally, they launched a first-of-its-kind, start-up focused initiative called Edison Developer Program, to partner closely with the rapidly developing external AI ecosystem.

Karley has held several digital leadership roles across the health care spectrum, including work with Apple Health; Doctor on Demand, providing telemedicine businesss development strategies; Maximus, leading implementations of the Affordable Care Act exchanges at the state level; and conducting clinical and software research in the healthcare space at both Duke and Stanford Universities. Karley completed her Bachelor of Science in Biomedical Engineering from Duke University and her Master of Business Administration from Harvard Business School.

Related posts:

Entrepreneurs ‘Xcelerate’ Innovation At Pitch Competition HoloLens To Assess The Resectability Of Ovarian Cancer MediView XR Receives Investment from JobsOhio Growth Capital Fund MediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government